Astro-Med, Inc. (ALOT) - 10-K Summary
Business Context and Reporting Period
Company: Astro-Med, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: January 31, 2011
Business Overview: Astro-Med designs, develops, manufactures, and distributes specialty printers and data acquisition/analysis systems. Operations are organized into three segments: Test & Measurement (T&M), QuickLabel Systems, and Grass Technologies. The company serves aerospace, automotive, life sciences, and general manufacturing markets globally, with approximately 30% of sales derived from international customers.
Key Financial Metrics
| Metric ($ in thousands) | Fiscal 2011 | Fiscal 2010 |
|---|---|---|
| Net Sales | $71,016 | $64,031 |
| Gross Profit | $28,666 | $26,628 |
| Gross Margin | 40.4% | 41.6% |
| Operating Income | $2,760 | $3,354 |
| Net Income | $2,062 | $2,766 |
| Diluted EPS | $0.28 | $0.38 |
| Cash from Operations | $1,110 | $5,850 |
| Cash & Equivalents | $7,720 | $14,155 |
| Debt | $0 (No borrowings on $5M line of credit) | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.9% to $71.0 million, driven primarily by an 18.6% increase in QuickLabel sales and a 4.1% increase in T&M sales. Grass Technologies sales grew slightly by 1.1%.
- Profitability Decline: Despite revenue growth, Net Income decreased 25.5% to $2.1 million. This was primarily due to a significant reduction in "Gain on Legal Settlement" (from $1.39M in 2010 to $0.1M in 2011) and lower investment income.
- Margin Compression: Gross margin declined to 40.4% from 41.6% due to an unfavorable product mix (lower margin products), higher manufacturing costs, and lower factory absorption.
- Cash Flow Deterioration: Operating cash flow dropped significantly to $1.1 million from $5.9 million, attributed to higher working capital requirements, specifically a $1.9M increase in accounts receivable and a $2.4M increase in inventory.
- Segment Performance:
- QuickLabel: Sales up 18.6% due to consumable demand and the Asheboro acquisition; however, operating margin fell to 4.7% from 7.6%.
- Grass Technologies: Operating profit surged 51.5% to $3.4M (20.1% margin) due to favorable product mix and lower costs, despite flat sales.
- T&M: Sales up 4.1% with stable operating margin at 8.1%.
Guidance, Outlook, and Risks
Outlook: Management expects to finance future needs through internal funds and a $5.0 million revolving line of credit. The company anticipates continued focus on R&D (7.1% of sales) and organic growth through product innovation.
Risks and Contingencies:
- Economic Sensitivity: Results are sensitive to global economic conditions, which may reduce demand for capital equipment and increase order cancellations.
- International Exposure: Approximately 30% of revenue is international, exposing the company to currency fluctuations, geopolitical risks, and trade regulations.
- Regulatory Compliance: Grass Technologies products are subject to FDA regulation; non-compliance could result in fines or production shutdowns.
- Legal Settlements: The 2010 results were significantly boosted by a $1.4M legal settlement gain, which is not expected to recur at similar levels.
Investor Verification Checklist
- Recurring Earnings: Verify core operating profitability by excluding the one-time legal settlement gains ($104k in 2011 vs $1.39M in 2010) to assess true operational trends.
- Working Capital Efficiency: Investigate the causes of the increased Days Sales Outstanding (54 days vs 49 days) and Inventory Days on Hand (124 days vs 114 days), which strained cash flow.
- QuickLabel Margin Pressure: Review the specific cost drivers and product mix changes causing the QuickLabel segment margin to drop from 7.6% to 4.7% despite strong sales growth.
- Acquisition Integration: Assess the performance of the Label Line acquisition (Asheboro, NC) and whether the projected synergies are being realized.
- Debt Capacity: Confirm the status of the $5.0M Wells Fargo line of credit and any covenants that may restrict future operations.